Journal of Current Glaucoma Practice

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  18 (2024)
Volume  17 (2023)
Volume  16 (2022)
Volume  15 (2021)
Volume  14 (2020)
Volume  13 (2019)
Volume  12 (2018)
Volume  11 (2017)
Volume  10 (2016)
Volume  9 (2015)
Volume  8 (2014)
Volume  7 (2013)
Volume  6 (2012)
Related articles

VOLUME 18 , ISSUE 2 ( April-June, 2024 ) > List of Articles

ORIGINAL RESEARCH

Expanded Polytetrafluoroethylene Spacer for Nonpenetrating Deep Sclerectomy Combined with Cataract Surgery

Maryam Hajizadeh, Aidin Meshksar, Kiana Hassanpour, Saeed Rahmani, Sadid Hooshmandi, Azadeh Doozandeh, Farideh Sharifipour, Shahin Yazdani, Mohammad Pakravan, Azadeh Samaeili

Keywords : Expanded polytetrafluoroethylene, Glaucoma, Intraocular pressure, Nonpenetrating deep sclerectomy

Citation Information : Hajizadeh M, Meshksar A, Hassanpour K, Rahmani S, Hooshmandi S, Doozandeh A, Sharifipour F, Yazdani S, Pakravan M, Samaeili A. Expanded Polytetrafluoroethylene Spacer for Nonpenetrating Deep Sclerectomy Combined with Cataract Surgery. J Curr Glaucoma Pract 2024; 18 (2):51-56.

DOI: 10.5005/jp-journals-10078-1432

License: CC BY-NC 4.0

Published Online: 10-07-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Purpose: To compare the outcomes of nonpenetrating deep sclerectomy (NPDS) with and without an expanded polytetrafluoroethylene (e-PTFE) implant combined with phacoemulsification (PE). Design: Interventional case series with concurrent control group. Materials and methods: Patients with medically uncontrolled glaucoma underwent PE nonpenetrating deep sclerectomy (NPDS) and were consecutively divided into a study group receiving an e-PTFE implant and a control group undergoing PE-NPDS. Intraocular pressure (IOP), corrected distance visual acuity (CDVA), and the number of glaucoma medications at 1 day, 1 week, 1 month, 3 months, and 6 months were recorded. Results: A total of 22 eyes of 16 patients underwent PE-NPDS, including 11 eyes receiving an e-PTFE implant and another 11 eyes with no implant. NPDS with spacer achieved successful results in all patients, including eight (72.7%) complete and three (27.3%) qualified success, 6 months, postoperatively. The corresponding values in the control group were 10 (90.9%) and 1 (9.1%), respectively. In the spacer group, mean IOP was decreased from 19.3 ± 2.8 at baseline to 12.1 ± 2.0 mm Hg at month 6 (p < 0.001). Corresponding values for the control group were 18.6 ± 3.4 and 10.6 ± 1.5 mm Hg, respectively (p < 0.001). Mean IOPs were comparable between the study groups at all time points. Implant exposure occurred in one of the patients in the study group. While the implant was extruded, the IOP was medically controlled. Conclusion: Outcomes of PE-NPDS using an e-PTFE implant were comparable to the same surgery without a spacer in the short term. Larger studies with longer follow-ups are needed to determine the efficacy and safety of this new implant.

HTML PDF Share
  1. Elbably A, M Othman T, Mousa A, et al. Deep sclerectomy with porous collagen in open-angle glaucoma, short-term study. J Curr Glaucoma Pract 2018;12(2):85–89. DOI: 10.5005/jp-journals-10008-1249
  2. Hui MM, Clement CI. Evaluation of the early to mid-term efficacy and safety of deep sclerectomy without an intrascleral spacer for open-angle glaucoma in an Australian population. J Curr Glaucoma Pract 2018;12(3):107–112. DOI: 10.5005/jp-journals-10028-1254
  3. Fedorov S, Ioffe D, Ronkina T. Glaucoma surgery–deep sclerectomy. Vestnik oftalmologii 1982;(4):6–10.
  4. Kozlov V, Bagrov S, Anisimova SY, et al. Nonpenetrating deep sclerectomy with collagen. Eye Microsurg 1990;3:44–46.
  5. Aptel F, Dumas S, Denis P. Ultrasound biomicroscopy and optical coherence tomography imaging of filtering blebs after deep sclerectomy with new collagen implant. Eur J Ophthalmol 2009;19(2):223–230. DOI: 10.1177/112067210901900208
  6. Paletta Guedes RA, Gravina DM, Paletta Guedes VM, et al. Use of a collagen matrix implant as an adjuvant in combined surgery involving phacoemulsification and nonpenetrating deep sclerectomy. J Glaucoma 2019;28(4):363–366. DOI: 10.1097/IJG.0000000000001191
  7. Ambresin A, Shaarawy T, Mermoud A. Deep sclerectomy with collagen implant in one eye compared with trabeculectomy in the other eye of the same patient. J Glaucoma 2002;11(3):214–220. DOI: 10.1097/00061198-200206000-00009
  8. Nishida K, Sakaguchi H, Xie P, et al. Biocompatibility and durability of Teflon-coated platinum-iridium wires implanted in the vitreous cavity. J Artif Organs 2011;14(4):357–363. DOI: 10.1007/s10047-011-0591-7
  9. Wolter J, Fralick F. Use of teflon in retinal separation surgery. Trans Am Ophthalmol Soc 1966;64:185.
  10. Ebnesajjad S. Expanded PTFE Applications Handbook: Technology, Manufacturing and Applications: William Andrew. 2016.
  11. Leszczynski R, Gumula T, Stodolak-Zych E, et al. Histopathological evaluation of a hydrophobic terpolymer (PTFE-PVD-PP) as an implant material for nonpenetrating very deep sclerectomy. Invest Ophthalmol Vis Sci 2015;56(9):5203–5209. DOI: 10.1167/iovs.14-16027
  12. Leszczynski R, Stodolak E, Wieczorek J, et al. In vivo biocompatibility assessment of (PTFE-PVDF-PP) terpolymer-based membrane with potential application for glaucoma treatment. J Mater Sci Mater Med 2010;21(10):2843–2851. DOI: 10.1007/s10856-010-4132-3
  13. Shaarawy T, Karlen M, Schnyder C, et al. Five-year results of deep sclerectomy with collagen implant. J Cataract Refract Surg 2001;27(11):1770–1778. DOI: 10.1016/s0886-3350(01)01032-x
  14. Shaarawy T, Mansouri K, Schnyder C, et al. Long-term results of deep sclerectomy with collagen implant. J Cataract Refract Surg 2004;30(6):1225–1231. DOI: 10.1016/j.jcrs.2003.10.035
  15. Shaarawy T, Nguyen C, Schnyder C, et al. Comparative study between deep sclerectomy with and without collagen implant: long term follow up. Br J Ophthalmol 2004;88(1):95–98. DOI: 10.1136/bjo.88.1.95
  16. Mansouri K, Shaarawy T, Wedrich A, et al. Comparing polymethylmethacrylate implant with collagen implant in deep sclerectomy: a randomized controlled trial. J Glaucoma 2006;15(3):264–270. DOI: 10.1097/01.ijg.0000212211.33265.6d
  17. Sanchez E, Schnyder CC, Sickenberg M, et al. Deep sclerectomy: results with and without collagen implant. Int Ophthalmol 1996-1997;20(1-3):157–162. DOI: 10.1007/BF00212963
  18. Bae HB, Kim CS, Ahn BH. A membranous drainage implant in glaucoma filtering surgery: animal trial. Korean J Ophthalmol 1988;2(2):49–56. DOI: 10.3341/kjo.1988.2.2.49
  19. Kim C, Kim Y, Choi S, et al. Clinical experience of e-PTFE membrane implant surgery for refractory glaucoma. Br J Ophthalmol 2003;87(1):63–70. DOI: 10.1136/bjo.87.1.63
  20. Shastri VP. Non-degradable biocompatible polymers in medicine: past, present and future. Curr Pharm Biotechnol 2003;4(5):331–337. DOI: 10.2174/1389201033489694
  21. Choi YJ, Kim CS, Ahn BH. A comparison of the clinical effect between e-PTFE membrane-tube implant and Ahmed glaucoma valve implant for the treatment of refractory glaucoma. Korean J Ophthalmol 2003;17(2):106–113. DOI: 10.3341/kjo.2003.17.2.106
  22. Cillino S, Zeppa L, Di Pace F, et al. E-PTFE (Gore-Tex) implant with or without low-dosage mitomycin-C as an adjuvant in penetrating glaucoma surgery: 2 year randomized clinical trial. Acta Ophthalmol 2008;86(3):314–321. DOI: 10.1111/j.1600-0420.2007.01036.x
  23. Samaeili A, Rahmani S, Hassanpour K, et al. A new glaucoma drainage implant with the use of polytetrafluoroethylene (PTFE). A pilot study. Rom J Ophthalmol 2021;65(2):150–156. DOI: 10.22336/rjo.2021.30
  24. DeCroos FC, Ahmad S, Kondo Y, et al. Expanded polytetrafluoroethylene membrane alters tissue response to implanted Ahmed glaucoma valve. Curr Eye Res 2009;34(7):562–567. DOI: 10.1080/02713680902963167
  25. Bicket AK, Szeto J, Roeber P, et al. A novel bilayered expanded polytetrafluoroethylene glaucoma implant creates a permeable thin capsule independent of aqueous humor exposure. Bioeng Transl Med 2021;6(1):e10179. DOI: 10.1002/btm2.10179
  26. Asrani S, Zeimer R, Wilensky J, et al. Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma 2000;9(2):134–142. DOI: 10.1097/00061198-200004000-00002
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.